
Elisa M. Rice
Examiner (ID: 18639, Phone: (571)270-1582 , Office: P/2669 )
| Most Active Art Unit | 2669 |
| Art Unit(s) | 2669, 2624 |
| Total Applications | 370 |
| Issued Applications | 269 |
| Pending Applications | 9 |
| Abandoned Applications | 94 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10728184
[patent_doc_number] => 20160074333
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-17
[patent_title] => 'Pharmaceutical compositions of tamsulosin or salts thereof'
[patent_app_type] => utility
[patent_app_number] => 14/767625
[patent_app_country] => US
[patent_app_date] => 2014-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5194
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14767625
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/767625 | Pharmaceutical compositions of tamsulosin or salts thereof | Jun 13, 2014 | Abandoned |
Array
(
[id] => 9756346
[patent_doc_number] => 20140287047
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-25
[patent_title] => 'NANOEMULSION THERAPEUTIC COMPOSITIONS AND METHODS OF USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 14/299350
[patent_app_country] => US
[patent_app_date] => 2014-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 37474
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14299350
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/299350 | Nanoemulsion therapeutic compositions and methods of using the same | Jun 8, 2014 | Issued |
Array
(
[id] => 9756350
[patent_doc_number] => 20140287051
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-25
[patent_title] => 'ORALLY ADMINISTERED CORTICOSTEROID COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 14/294660
[patent_app_country] => US
[patent_app_date] => 2014-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9238
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14294660
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/294660 | Orally administered corticosteroid compositions | Jun 2, 2014 | Issued |
Array
(
[id] => 10760551
[patent_doc_number] => 20160106704
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-21
[patent_title] => 'METHODS FOR DELIVERING CROMOLYN'
[patent_app_type] => utility
[patent_app_number] => 14/893487
[patent_app_country] => US
[patent_app_date] => 2014-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9868
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14893487
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/893487 | Methods for delivering cromolyn | May 21, 2014 | Issued |
Array
(
[id] => 9719797
[patent_doc_number] => 20140255494
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-11
[patent_title] => 'Novel Formulation of Indomethacin'
[patent_app_type] => utility
[patent_app_number] => 14/284981
[patent_app_country] => US
[patent_app_date] => 2014-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 42148
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14284981
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/284981 | Formulation of indomethacin | May 21, 2014 | Issued |
Array
(
[id] => 9721080
[patent_doc_number] => 20140256781
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-11
[patent_title] => 'Novel Formulation of Indomethacin'
[patent_app_type] => utility
[patent_app_number] => 14/282915
[patent_app_country] => US
[patent_app_date] => 2014-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 41990
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14282915
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/282915 | Formulation of indomethacin | May 19, 2014 | Issued |
Array
(
[id] => 9719794
[patent_doc_number] => 20140255493
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-11
[patent_title] => 'EXTRUDATE AND METHODS OF USING SAID EXTRUDATE'
[patent_app_type] => utility
[patent_app_number] => 14/281258
[patent_app_country] => US
[patent_app_date] => 2014-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3338
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14281258
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/281258 | Extrudate and methods of using said extrudate | May 18, 2014 | Issued |
Array
(
[id] => 10953282
[patent_doc_number] => 20140356303
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-04
[patent_title] => 'Natural Silicone Replacements for Silicone Fluids in Personal Care Formulations'
[patent_app_type] => utility
[patent_app_number] => 14/276788
[patent_app_country] => US
[patent_app_date] => 2014-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 6655
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14276788
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/276788 | Natural silicone replacements for silicone fluids in personal care formulations | May 12, 2014 | Issued |
Array
(
[id] => 10069500
[patent_doc_number] => 09107835
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-08-18
[patent_title] => 'Chewable enteric coated aspirin tablets'
[patent_app_type] => utility
[patent_app_number] => 14/274853
[patent_app_country] => US
[patent_app_date] => 2014-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4360
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14274853
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/274853 | Chewable enteric coated aspirin tablets | May 11, 2014 | Issued |
Array
(
[id] => 9685394
[patent_doc_number] => 20140242159
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-28
[patent_title] => 'Method for Preparing a Granulate Formulation of Pirfenidone and Pharmaceutically Acceptable Excipients'
[patent_app_type] => utility
[patent_app_number] => 14/271720
[patent_app_country] => US
[patent_app_date] => 2014-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 6065
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14271720
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/271720 | Method for Preparing a Granulate Formulation of Pirfenidone and Pharmaceutically Acceptable Excipients | May 6, 2014 | Abandoned |
Array
(
[id] => 10919305
[patent_doc_number] => 20140322323
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-30
[patent_title] => 'PHARMACEUTICAL DOSAGE FORM'
[patent_app_type] => utility
[patent_app_number] => 14/261625
[patent_app_country] => US
[patent_app_date] => 2014-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 49485
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14261625
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/261625 | PHARMACEUTICAL DOSAGE FORM | Apr 24, 2014 | Abandoned |
Array
(
[id] => 12036591
[patent_doc_number] => 09814805
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-11-14
[patent_title] => 'Coatings for controlled release of highly water soluble drugs'
[patent_app_type] => utility
[patent_app_number] => 14/786842
[patent_app_country] => US
[patent_app_date] => 2014-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 11601
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14786842
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/786842 | Coatings for controlled release of highly water soluble drugs | Apr 24, 2014 | Issued |
Array
(
[id] => 9671853
[patent_doc_number] => 20140235716
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-21
[patent_title] => 'STABLE PHARMACEUTICAL COMPOSITION AND METHODS OF USING SAME'
[patent_app_type] => utility
[patent_app_number] => 14/259724
[patent_app_country] => US
[patent_app_date] => 2014-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16205
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14259724
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/259724 | Stable pharmaceutical composition and methods of using same | Apr 22, 2014 | Issued |
Array
(
[id] => 10721006
[patent_doc_number] => 20160067153
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-10
[patent_title] => 'Translucent gel system'
[patent_app_type] => utility
[patent_app_number] => 14/787511
[patent_app_country] => US
[patent_app_date] => 2014-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4081
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14787511
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/787511 | Translucent gel system | Apr 22, 2014 | Issued |
Array
(
[id] => 10095914
[patent_doc_number] => 09132211
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-09-15
[patent_title] => 'Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens'
[patent_app_type] => utility
[patent_app_number] => 14/254160
[patent_app_country] => US
[patent_app_date] => 2014-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 12805
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14254160
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/254160 | Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens | Apr 15, 2014 | Issued |
Array
(
[id] => 10705806
[patent_doc_number] => 20160051953
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-25
[patent_title] => 'FUNCTIONAL FLUID'
[patent_app_type] => utility
[patent_app_number] => 14/784468
[patent_app_country] => US
[patent_app_date] => 2014-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4369
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14784468
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/784468 | Functional fluid | Apr 9, 2014 | Issued |
Array
(
[id] => 10704814
[patent_doc_number] => 20160050961
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-25
[patent_title] => 'FOOD SUPPLEMENT FOR PEOPLE WITH DOWN SYNDROME, AUTISM SPECTRUM DISORDER AND/OR ATTENTION DEFICIT DISORDER WITH OR WITHOUT HYPERACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 14/780596
[patent_app_country] => US
[patent_app_date] => 2014-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 14143
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14780596
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/780596 | FOOD SUPPLEMENT FOR PEOPLE WITH DOWN SYNDROME, AUTISM SPECTRUM DISORDER AND/OR ATTENTION DEFICIT DISORDER WITH OR WITHOUT HYPERACTIVITY | Mar 26, 2014 | Abandoned |
Array
(
[id] => 13116273
[patent_doc_number] => 10076472
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-09-18
[patent_title] => Aqueous composition comprising hydrophobic silica aerogel particles, a deodorant agent and/or an antiperspirant active agent and a specific alcohol
[patent_app_type] => utility
[patent_app_number] => 14/783566
[patent_app_country] => US
[patent_app_date] => 2014-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6868
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 187
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14783566
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/783566 | Aqueous composition comprising hydrophobic silica aerogel particles, a deodorant agent and/or an antiperspirant active agent and a specific alcohol | Mar 19, 2014 | Issued |
Array
(
[id] => 10699295
[patent_doc_number] => 20160045441
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-18
[patent_title] => 'Pharmaceutical Compositions Comprising Everolimus'
[patent_app_type] => utility
[patent_app_number] => 14/773795
[patent_app_country] => US
[patent_app_date] => 2014-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 26283
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 36
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14773795
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/773795 | Pharmaceutical Compositions Comprising Everolimus | Mar 18, 2014 | Abandoned |
Array
(
[id] => 9740736
[patent_doc_number] => 20140276456
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-18
[patent_title] => 'INTRAVENOUS CONNECTOR HAVING ANTIMICROBIAL TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 14/216020
[patent_app_country] => US
[patent_app_date] => 2014-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 2471
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14216020
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/216020 | Intravenous connector having antimicrobial treatment | Mar 16, 2014 | Issued |